CELLCEPT 500MG – Composition, Uses and Medicine Enquiries
Product Overview
CELLCEPT 500MG is listed as a prescription product containing Mycophenolate mofetil 500MG, marketed in the source catalogue by Roche Products India Pvt Ltd.
It belongs to the immunosuppressant; antimetabolite class and may be prescribed for the prevention of rejection after certain organ transplants.
Its active ingredient reduces the proliferation of immune cells involved in transplant rejection.
The exact manufacturer pack, formulation, approved indication and administration schedule must be checked before treatment or publication. A qualified clinician should assess suitability, interactions, contraindications and monitoring requirements.
Major pregnancy risks, infections and blood count changes require close monitoring.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Mycophenolate mofetil | 500MG |
Product Name: CELLCEPT 500MG
Generic Name: Mycophenolate mofetil
Brand Name: CELLCEPT 500MG
Strength: 500MG
Listed Marketer: Roche Products India Pvt Ltd
The composition and strength should be verified against the original manufacturer-labelled packaging before publication or any medicine enquiry.
Therapeutic Category and Indication
CELLCEPT 500MG belongs to the immunosuppressant category and is classified as an antimetabolite.
It may be prescribed for the prevention of rejection after certain organ transplants.
Mycophenolate mofetil reduces the proliferation of immune cells involved in transplant rejection.
Treatment choice depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The benefit-risk balance, approved use and monitoring plan must be determined by the treating specialist.
Major pregnancy risks, infections and blood count changes require close monitoring.
Administration Information
The supplied product information identifies an oral tablet taken as prescribed by the transplant team.
The tablet should be swallowed whole.
Patients should follow only the treating clinician’s instructions and the approved product label. They should not independently adjust the dose, skip safety monitoring or switch formulations without medical advice.
The exact administration schedule must be verified against the approved product information.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: CELLCEPT 500MG
- Generic Name: Mycophenolate mofetil
- Strength: 500MG
- Company Name: Roche Products India Pvt Ltd
- Therapeutic Category: Immunosuppressant
- Medicine Class: Antimetabolite
- Indication: Prevention of rejection after certain organ transplants
- Administration: Oral tablet
The exact dosage form, pack size, batch, storage, expiry and product-specific presentation require verification from original manufacturer packaging and an authorised provider.
Product details and supply eligibility may vary by country. A product listing does not confirm current stock or availability.
Prescription and Patient Safety
CELLCEPT 500MG is listed as a prescription medicine and requires specialist supervision.
Treatment suitability, contraindications, interactions and monitoring requirements must be evaluated by the treating specialist.
Major pregnancy risks, infections and blood count changes require close monitoring.
Patients should follow the approved product label and their transplant team’s instructions. They should not independently change the treatment schedule or discontinue treatment.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal is a healthcare coordination platform. It can receive medicine information requests and, where legally permissible, connect patients or institutions with appropriately authorised independent pharmaceutical providers.
Medinglobal does not itself sell, dispense, manufacture or export medicines.
Product availability, lawful supply, prescription validation, commercial terms and destination requirements must be verified by the independent provider. Submitting an enquiry does not guarantee fulfilment.
How to Submit a CELLCEPT 500MG Enquiry
To help identify the requested product, include the following details:
- Product name: CELLCEPT 500MG.
- Generic name: Mycophenolate mofetil.
- Required strength: 500MG.
- Required formulation and quantity.
- Destination country.
- Valid prescription or institutional documents, where required.
Medinglobal may coordinate an introduction to a suitably authorised provider. The provider independently verifies product details, regulatory eligibility and any transaction.
Frequently Asked Questions
What is CELLCEPT 500MG used for?
CELLCEPT 500MG is associated with the prevention of rejection after certain organ transplants. The treating prescriber confirms the approved use.
What is the composition of CELLCEPT 500MG?
The supplied catalogue lists Mycophenolate mofetil 500MG as its active ingredient. The composition should be verified against the original product packaging.
How is CELLCEPT 500MG administered?
The supplied information identifies an oral tablet taken as prescribed by the transplant team and swallowed whole.
Which company is listed for CELLCEPT 500MG?
Roche Products India Pvt Ltd is listed as the marketer in the supplied product information.
Does CELLCEPT 500MG require medical supervision?
Yes. Treatment requires specialist supervision and monitoring, particularly regarding pregnancy risks, infections and blood count changes.
Can Medinglobal supply CELLCEPT 500MG directly?
No. Medinglobal coordinates medicine enquiries with independent authorised providers where legally permissible.

Reviews
There are no reviews yet.